Antifibrotic effect of angiotensin blockers in hypertensive hepatitis C patients.
Bahde
Ralf
R
Kapoor
Sorabh
S
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008103:Liver Cirrhosis / Q000188:drug therapy*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors